Literature DB >> 20926024

Increased levels of soluble vascular endothelial cadherin are associated with poor outcome in severe sepsis.

R-Y Zhang1, Y-Y Liu, L Li, W Cui, K-J Zhao, W-C Huang, X-W Gu, W Liu, J Wu, D Min, E-Q Mao, Y-Q Tang.   

Abstract

Endothelial cells are thought to play a key role in sepsis pathogenesis: vascular endothelial damage occurs in severe sepsis and multiple organ dysfunction. Soluble vascular endothelial cadherin (VE-cadherin) levels were investigated in a prospective study involving 28 consecutive critically ill patients with or without severe sepsis who were admitted to surgical intensive care; 13 healthy age-matched volunteers were included as controls. Soluble VE-cadherin levels increased significantly in patients with severe sepsis compared with ill patients without severe sepsis and healthy controls. There was a significant linear correlation between soluble VE-cadherin levels and illness severity scores. Soluble VE-cadherin levels were significantly higher in patients who died compared with survivors. In vitro cell culture showed that serum from patients with severe sepsis greatly decreased VE-cadherin staining at intercellular junctions and total VE-cadherin expression in human umbilical cord vein endothelial cells. These findings suggest that endothelial cells play an important role in the poor outcome of patients with severe sepsis.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20926024     DOI: 10.1177/147323001003800433

Source DB:  PubMed          Journal:  J Int Med Res        ISSN: 0300-0605            Impact factor:   1.671


  9 in total

Review 1.  Endothelial Cell Junctional Adhesion Molecules: Role and Regulation of Expression in Inflammation.

Authors:  Natalia Reglero-Real; Bartomeu Colom; Jennifer Victoria Bodkin; Sussan Nourshargh
Journal:  Arterioscler Thromb Vasc Biol       Date:  2016-08-11       Impact factor: 8.311

2.  Soluble vascular endothelial-cadherin in CSF after subarachnoid hemorrhage.

Authors:  Hajime Takase; Sherry Hsiang-Yi Chou; Gen Hamanaka; Ryo Ohtomo; Mohammad R Islam; Jong Woo Lee; Liangge Hsu; Justin Mathew; Estefania Reyes-Bricio; Kazuhide Hayakawa; Changhong Xing; Ming Ming Ning; Xiaoying Wang; Ken Arai; Eng H Lo; Josephine Lok
Journal:  Neurology       Date:  2020-02-27       Impact factor: 9.910

3.  Soluble vascular endothelial cadherin: a promising marker of critical illness?

Authors:  Ruyuan Zhang; Ranran Li; Yaoqing Tang
Journal:  Crit Care       Date:  2019-02-19       Impact factor: 9.097

4.  Circulating Biomarkers of Cell Adhesion Predict Clinical Outcome in Patients with Chronic Heart Failure.

Authors:  Elke Bouwens; Victor J van den Berg; K Martijn Akkerhuis; Sara J Baart; Kadir Caliskan; Jasper J Brugts; Henk Mouthaan; Jan van Ramshorst; Tjeerd Germans; Victor A W M Umans; Eric Boersma; Isabella Kardys
Journal:  J Clin Med       Date:  2020-01-10       Impact factor: 4.241

Review 5.  A new perspective in sepsis treatment: could RGD-dependent integrins be novel targets?

Authors:  Danielle Nader; Gerard F Curley; Steven W Kerrigan
Journal:  Drug Discov Today       Date:  2020-10-06       Impact factor: 7.851

6.  ICU Admission Levels of Endothelial Biomarkers as Predictors of Mortality in Critically Ill COVID-19 Patients.

Authors:  Alice G Vassiliou; Chrysi Keskinidou; Edison Jahaj; Parisis Gallos; Ioanna Dimopoulou; Anastasia Kotanidou; Stylianos E Orfanos
Journal:  Cells       Date:  2021-01-19       Impact factor: 6.600

7.  Soluble plasma VE-cadherin concentrations are elevated in patients with STEC infection and haemolytic uraemic syndrome: a case-control study.

Authors:  Julia Doulgere; Benjamin Otto; Maher Nassour; Gerrit Wolters-Eisfeld; Holger Rohde; Tim Magnus; Christoph Wagener; Thomas Streichert
Journal:  BMJ Open       Date:  2015-03-10       Impact factor: 2.692

8.  Autoantibodies targeting AT1 receptor from patients with acute coronary syndrome upregulate proinflammatory cytokines expression in endothelial cells involving NF-κB pathway.

Authors:  Weijuan Li; Zhi Li; Yaoqi Chen; Songhai Li; Yuanyuan Lv; Wenping Zhou; Mengyang Liao; Feng Zhu; Zihua Zhou; Xiang Cheng; Qiutang Zeng; Yuhua Liao; Yumiao Wei
Journal:  J Immunol Res       Date:  2014-11-30       Impact factor: 4.818

9.  Elevated levels of circulating CDH5 and FABP1 in association with human drug-induced liver injury.

Authors:  Maria Mikus; Kimi Drobin; Marcus Gry; Julie Bachmann; Johan Lindberg; Getnet Yimer; Eleni Aklillu; Eyasu Makonnen; Getachew Aderaye; James Roach; Ian Fier; Caroline Kampf; Jens Göpfert; Hugo Perazzo; Thierry Poynard; Camilla Stephens; Raúl J Andrade; M Isabel Lucena; Nadir Arber; Mathias Uhlén; Paul B Watkins; Jochen M Schwenk; Peter Nilsson; Ina Schuppe-Koistinen
Journal:  Liver Int       Date:  2016-06-22       Impact factor: 5.828

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.